Coagulopathy in COVID-19 and anticoagulation clinical trials

Severe acute respiratory disease coronavirus 2 (SARS-COV-2) first emerged in Wuhan, China, in December 2019 and has caused a global pandemic of a scale unprecedented in the modern era. People infected with SARS-CoV-2 can be asymptomatic, moderate symptomatic or develop severe COVID-19. Other than th...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Heng, Lao, Qifang, Zhang, Jue, Zhu, Jieqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9395291/
https://www.ncbi.nlm.nih.gov/pubmed/36494146
http://dx.doi.org/10.1016/j.beha.2022.101377

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9395291/
https://www.ncbi.nlm.nih.gov/pubmed/36494146
http://dx.doi.org/10.1016/j.beha.2022.101377

Ejemplares similares